References
- MerinoSMartínCKostarelosKPratoMVázquezENanocomposite hydrogels: 3D polymer-nanoparticle synergies for on-demand drug deliveryACS Nano2015954686469725938172
- SepantafarMMaheronnaghshRMohammadiHEngineered hydrogels in cancer therapy and diagnosisTrends Biotechnol201735111074108728734545
- MarusykAAlmendroVPolyakKIntra-tumour heterogeneity: a looking glass for cancer?Nat Rev Cancer201212532333422513401
- SenftDLeisersonMDMRuppinERonaiZAPrecision oncology: the road aheadTrends Mol Med2017231087489828887051
- JoungJGOhBYHongHKTumor heterogeneity predicts metastatic potential in colorectal cancerClin Cancer Res201723237209721628939741
- RavasioRCeccacciEMinucciSSelf-renewal of tumor cells: epigenetic determinants of the cancer stem cell phenotypeCurr Opin Genet Dev201636929927153353
- BatlleECleversHCancer stem cells revisitedNat Med201723101124113428985214
- García-RubiñoMELozano-LópezCCamposJMInhibitors of cancer stem cellsAnticancer Agents Med Chem201616101230123927025655
- ShibueTWeinbergRAEMT, CSCs, and drug resistance: the mechanistic link and clinical implicationsNat Rev Clin Oncol2017141061162928397828
- GuptaPBOnderTTJiangGIdentification of selective inhibitors of cancer stem cells by high-throughput screeningCell2009138464565919682730
- FuYZYanYYHeMSalinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathwayOncol Rep201635291292226718029
- DewanganJSrivastavaSRathSKSalinomycin: A new paradigm in cancer therapyTumour Biol2017393 1010428317695035
- NaujokatCSteinhartRSalinomycin as a drug for targeting human cancer stem cellsJ Biomed Biotechnol201220129506581723251084
- BoehmerleWMuenzfeldHSpringerAHuehnchenPEndresMSpecific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in miceJ Mol Med201492888990024770997
- MilanovicMFanDNYBelenkiDSenescence-associated reprogramming promotes cancer stemnessNature201855376869610029258294
- LarzabalLEl-NikhelyNRedradoMDifferential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasisPLoS One2013811e7979824278179
- MaoJSongBShiYShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxelInt J Biochem Cell Biol20134561064107323500524
- ZhangYZhangHWangXThe eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micellesBiomaterials201233267969122019123
- MuntimaduguEKumarRSaladiSRafeeqiTAKhanWCD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxelColloids Surf B Biointerfaces201614353254627045981
- KuoSZBlairKJRahimyESalinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and AktBMC Cancer20121255623176396
- MaitzMFSperlingCWongpinyochitTBiocompatibility assessment of silk nanoparticles: hemocompatibility and internalization by human blood cellsNanomedicine20171382633264228757180
- OmenettoFGKaplanDLNew opportunities for an ancient materialScience2010329599152853120671180
- RaiaNRPartlowBPMcGillMEnzymatically crosslinked silk-hyaluronic acid hydrogelsBiomaterials2017131586728376366
- SuDYaoMLiuJEnhancing mechanical properties of silk fibroin hydrogel through restricting the growth of β-sheet domainsACS Appl Mater Interfaces2017920174891749828470062
- WangXKlugeJALeiskGGKaplanDLSonication-induced gelation of silk fibroin for cell encapsulationBiomaterials20082981054106418031805
- ZhangWWangXWangSThe use of injectable sonication-induced silk hydrogel for VEGF165 and BMP-2 delivery for elevation of the maxillary sinus floorBiomaterials201132359415942421889205
- SeibFPPritchardEMKaplanDLSelf-assembling doxorubicin silk hydrogels for the focal treatment of primary breast cancerAdv Funct Mater2013231586523646041
- NumataKYamazakiSNagaNBiocompatible and biodegradable dual-drug release system based on silk hydrogel containing silk nanoparticlesBiomacromolecules20121351383138922471816
- WuPLiuQLiRFacile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug deliveryACS Appl Mater Interfaces2013523126381264524274601
- BianXWuPShaHAnti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiencyOnco Targets Ther201693153316227313461
- DusiGGambaVLiquid chromatography with ultraviolet detection of lasalocid, monensin, salinomycin and narasin in poultry feeds using pre-column derivatizationJ Chromatogr A19998351–224324610220924
- MishraLBankerTMurrayJLiver stem cells and hepatocellular carcinomaHepatology200949131832919111019
- KimUJParkJLiCStructure and properties of silk hydrogelsBiomacromolecules20045378679215132662
- MatsumotoAChenJColletteALMechanisms of silk fibroin sol-gel transitionsJ Phys Chem B200611043216302163817064118
- YucelTCebePKaplanDLVortex-induced injectable silk fibroin hydrogelsBiophys J20099772044205019804736
- NumataKKatashimaTSakaiTState of water, molecular structure, and cytotoxicity of silk hydrogelsBiomacromolecules20111262137214421517113
- WuXHouJLiMSodium dodecyl sulfate-induced rapid gelation of silk fibroinActa Biomater2012862185219222406911
- WuHLiuSXiaoLInjectable and pH-responsive silk nanofiber hydrogels for sustained anticancer drug deliveryACS Appl Mater Interfaces2016827171181712627315327
- CoburnJHarrisJZakharovADImplantable chemotherapy-loaded silk protein materials for neuroblastoma treatmentInt J Cancer2017140372673527770551
- TianYJiangXChenXShaoZYangWDoxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancerAdv Mater201426437393739825238148
- QuJLiuYYuYSilk fibroin nanoparticles prepared by electro-spray as controlled release carriers of cisplatinMater Sci Eng C Mater Biol Appl20144416617425280693
- LiHTianJWuASelf-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinomaInt J Nanomedicine2016114373438027621628
- XieMFanDChenYAn implantable and controlled drug-release silk fibroin nanofibrous matrix to advance the treatment of solid tumour cancersBiomaterials2016103334327376557
- LerdchaiKKitsongsermthonJRatanavarapornJKanokpanontSDamrongsakkulSThai silk fibroin/gelatin sponges for the dual controlled release of curcumin and docosahexaenoic acid for anticancer treatmentJ Pharm Sci2016105122123026579620
- GuziewiczNBestAPerez-RamirezBKaplanDLLyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodiesBiomaterials201132102642265021216004
- GuziewiczNAMassettiAJPerez-RamirezBJKaplanDLMechanisms of monoclonal antibody stabilization and release from silk biomaterialsBiomaterials201334317766777523859659
- van NeervenSMTiekenMVermeulenLBijlsmaMFBidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneityMol Cell Oncol201632e109879127308617